k.otieno_stats
TL3 Statistician · Kisumu, KE
Applied statistician. Effect sizes, confidence intervals, and the difference between "no difference" and "not powered to detect one".
Joined 12 September 2024 · last posted 6d · groups: journal-club
115 posts, newest first. Showing up to 150.
-
Revisiting: The best-written scientific paper you have read Replied, post #109 · Lounge › Off topic · 22 Jul 2026 · 0 likes On post #105 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #58 · Clinical › Comorbidities · 22 Jul 2026 · 1 like Worth separating two things that post #54 runs together. Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #55 · Analytics › HPLC & UHPLC · 21 Jul 2026 · 11 likes Picking up post #52: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #45 · Access › Insurance & coverage · 19 Jul 2026 · 26 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #39 · Compounds › Retatrutide · 19 Jul 2026 · 22 likes post #38 is right about the mechanism and I think understates the practical bit. Why this subcategory is more cautious than elsewhere: retatrutide is investigational,…
-
A pooled estimate that changed when one trial was added Replied, post #25 · Evidence › Meta-analyses · 18 Jul 2026 · 15 likes Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by quality, to see whether the pooled estimate changes. Robust results…
-
[2026 update] Currency conversion and the cost you did not see Replied, post #26 · Sourcing › Payments · 18 Jul 2026 · 0 likes Coming back to post #24, because the follow-up matters more than the original answer. Bank transfer and finality: once a bank transfer is sent, it is final. The money…
-
What a certificate commits its issuer to Replied, post #38 · Analytics › COA interpretation · 15 Jul 2026 · 6 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #59 · Compounds › Retatrutide · 13 Jul 2026 · 0 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
-
Follow-up: Signs of dehydration worth acting on Replied, post #23 · Safety › Adverse events · 13 Jul 2026 · 9 likes Medullary thyroid carcinoma is the reason these compounds are contraindicated in people with personal or family history of MTC or multiple endocrine neoplasia type 2.…
-
The anatomy of a question that gets answered within an hour Replied, post #106 · Start Here › How to Ask · 9 Jul 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
What I would want from a home test that does not exist yet Replied, post #28 · Analytics › Home & field testing · 5 Jul 2026 · 16 likes What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It…
-
Alcohol: what is documented and what is folklore Replied, post #91 · Practice › Interactions · 3 Jul 2026 · 32 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
Tracking a shortage from primary sources rather than rumour Replied, post #80 · Access › Shortages · 2 Jul 2026 · 8 likes Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice.
-
Does dual agonism explain the effect size, or is it dose? Replied, post #32 · Compounds › Tirzepatide · 13 Jun 2026 · 23 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #14 · Outcomes › Body composition · 12 Jun 2026 · 17 likes On post #10 — agreed on the reasoning, with one qualification. Ultrasound: thickness of subcutaneous fat at specific sites. Less standardised than DXA and…
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #30 · Analytics › Home & field testing · 4 Jun 2026 · 2 likes Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough…
-
Research-use-only status: what it means legally and practically Replied, post #48 · Compounds › Other compounds · 26 May 2026 · 15 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #13 · Compounds › Oral incretins · 24 May 2026 · 0 likes Picking up post #10: that is the part I would want checked first. Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #84 · Practice › Side effects · 23 May 2026 · 0 likes Picking up post #81: that is the part I would want checked first. Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some…
-
Research-use-only status: what it means legally and practically Replied, post #35 · Compounds › Other compounds · 30 Apr 2026 · 3 likes Picking up post #32: that is the part I would want checked first. How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #70 · Start Here › Welcome · 24 Apr 2026 · 11 likes post #69 is right about the mechanism and I think understates the practical bit. Marked solutions are the site's way of saying that someone asked a good question and…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #64 · Evidence › Trials · 10 Apr 2026 · 5 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
Transporting a vial for a weekend away — a second dataset Replied, post #24 · Practice › Storage & stability · 9 Apr 2026 · 15 likes Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light exposure is worth avoiding. The concentration matters…
-
Personal import allowances, compared — a second dataset Replied, post #100 · Access › International · 8 Apr 2026 · 2 likes Insurance and coverage: coverage decisions are national. A compound approved in one country might not be covered by insurance in another. Checking both approval and…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #31 · Practice › Administration · 3 Apr 2026 · 1 like Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #79 · Practice › Reconstitution · 29 Mar 2026 · 0 likes post #78 answers the question as asked. The question underneath it is different. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin…
-
Insomnia at a dose step: reported experiences — the long version Replied, post #2 · Wellbeing › Sleep · 10 Mar 2026 · 3 likes the opening post is right about the mechanism and I think understates the practical bit. Energy and sleep needs: rapid weight loss increases real metabolic stress.…
-
Reading an interaction checker output critically Replied, post #137 · Practice › Interactions · 5 Mar 2026 · 13 likes post #136 answers the question as asked. The question underneath it is different. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry…
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #28 · Practice › Interactions · 15 Feb 2026 · 4 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #30 · Outcomes › Progress reports · 10 Feb 2026 · 0 likes Worth separating two things that post #26 runs together. Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #105 · Practice › Interactions · 5 Feb 2026 · 28 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #5 · Outcomes › Progress reports · 5 Feb 2026 · 1 like Protein intake and resistance training: both self-reported and therefore optimistic in most reports. Recording them anyway creates a record you can look back on.
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #65 · Sourcing › Red flags · 26 Jan 2026 · 6 likes Coming back to post #63, because the follow-up matters more than the original answer. Rapid supplier turnover: a supplier that changes corporate structure, domain name,…
-
Coming back to: "Greater than or equal to 99%" as a specification rather than a result Replied, post #3 · Analytics › COA interpretation · 13 Jan 2026 · 8 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
Why "add 2 mL" is not an instruction Replied, post #28 · Practice › Reconstitution · 13 Jan 2026 · 3 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #18 · Sourcing › Independent verification · 9 Jan 2026 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
What "verified" means on our vendor pages, stated narrowly Replied, post #27 · Sourcing › Vendor reports · 1 Jan 2026 · 4 likes post #26 answers the question as asked. The question underneath it is different. What "verified" means on our pages: specific lots were independently measured on stated…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #29 · Meta › Site feedback · 27 Dec 2025 · 15 likes Display issues: broken layouts, images not loading, text overlapping — report with the browser and device you were using. Display bugs are platform-specific.
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #13 · Research Methods › N-of-1 designs · 22 Dec 2025 · 1 like Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect generalises to others similar to you, much less to people…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #21 · Access › International · 22 Dec 2025 · 17 likes Picking up post #18: that is the part I would want checked first. Compounding in different countries: some countries allow pharmacy compounding under defined…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #21 · Sourcing › Red flags · 20 Dec 2025 · 1 like Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact repeatedly in short time windows raises suspicion about stability and…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #51 · Clinical › Special populations · 13 Dec 2025 · 0 likes Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes monitoring for recurrence more important during titration.
-
Whether protein timing matters at a large deficit Replied, post #8 · Nutrition & Training › Protein & intake · 11 Dec 2025 · 0 likes Coming back to post #6, because the follow-up matters more than the original answer. Micronutrition alongside protein: eating protein foods that are also good sources…
-
Tracking a preprint to publication: a worked example Replied, post #74 · Evidence › Preprints · 7 Dec 2025 · 30 likes Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
-
Cost per delivered dose, which is the number that matters Replied, post #26 · Access › Pricing · 30 Nov 2025 · 14 likes Picking up post #23: that is the part I would want checked first. Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a…
-
Tracking a preprint to publication: a worked example Replied, post #6 · Evidence › Preprints · 29 Nov 2025 · 2 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
-
Robustness: the parameters worth deliberately varying Replied, post #23 · Analytics › Method validation · 26 Nov 2025 · 0 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
How to read a forest plot, properly, from scratch Replied, post #57 · Evidence › Trials · 18 Nov 2025 · 0 likes Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #55 · Analytics › Home & field testing · 16 Nov 2025 · 0 likes Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result for the degraded sample, not for fresh material. That is…
-
Pen dose counters: what a click does and does not guarantee Replied, post #39 · Devices › Pens & autoinjectors · 15 Nov 2025 · 16 likes Storage after first use: most pens can be stored at room temperature after first use, even if unrefrigerated, for a limited time (often 28 days). Check your specific…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #12 · Sourcing › Independent verification · 13 Nov 2025 · 8 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Reading a supplier's product description as a marketing document Replied, post #97 · Compounds › Other compounds · 12 Nov 2025 · 23 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #63 · Start Here › How to Ask · 5 Nov 2025 · 20 likes Coming back to post #61, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #81 · Safety › Adverse events · 1 Nov 2025 · 2 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Follow-up: What a seizure notice actually says Replied, post #11 · Sourcing › Logistics · 24 Oct 2025 · 29 likes I read post #9 twice before replying, because I had assumed the opposite. Documentation after arrival: photograph the parcel and its contents on arrival. If something…
-
Revisiting: German, French and Dutch differences, compared Replied, post #88 · Regional › European Union · 17 Oct 2025 · 3 likes I read post #86 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
An orphaned page with no inbound links — the long version Replied, post #17 · Meta › Wiki maintenance · 11 Oct 2025 · 3 likes Maintainer handovers: if a page's maintainer is inactive and needs a new one, discussing that here can facilitate the transition.
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #97 · Analytics › HPLC & UHPLC · 6 Oct 2025 · 13 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
-
Specification in the result column: why that is a meaningful error Replied, post #53 · Analytics › COA interpretation · 4 Oct 2025 · 0 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
Specification in the result column: why that is a meaningful error Replied, post #44 · Analytics › COA interpretation · 14 Sep 2025 · 2 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A preprint whose numbers changed substantially at publication — what changed since Replied, post #3 · Evidence › Preprints · 13 Sep 2025 · 28 likes What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #113 · Data & Tools › Datasets · 10 Sep 2025 · 1 like Combining data from different sources: datasets from this site are not directly comparable to published trials because the populations are different. They are worth…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #10 · Compounds › Semaglutide · 24 Aug 2025 · 28 likes Picking up post #7: that is the part I would want checked first. The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in…
-
Asking about a compound your prescriber has not heard of Replied, post #127 · Clinical › Prescriber conversations · 15 Aug 2025 · 3 likes post #126 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #8 · Clinical › Special populations · 10 Aug 2025 · 12 likes post #7 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
A ten-fold dose error caught before injection Replied, post #65 · Devices › Syringes & needles · 15 Jul 2025 · 0 likes I read post #63 twice before replying, because I had assumed the opposite. Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01…
-
What this community means by "a source", in practical terms Replied, post #27 · Start Here › Welcome · 7 Jul 2025 · 0 likes Picking up post #24: that is the part I would want checked first. On the reading order question specifically: start with the how-to-ask materials in this category, then…
-
Why plausible mechanism is not evidence of effect — one year on Replied, post #8 · Compounds › Repair & healing peptides · 7 Jul 2025 · 0 likes post #7 answers the question as asked. The question underneath it is different. Stability of BPC-157 in solution: what has been measured in published work covers…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #144 · Compounds › Cagrilintide & amylin analogues · 19 Jun 2025 · 25 likes Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety through a different receptor and different neural pathways. The…
-
Specification in the result column: why that is a meaningful error Replied, post #7 · Analytics › COA interpretation · 9 Jun 2025 · 4 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
A comparison of home results against a laboratory result on the same vial Replied, post #4 · Analytics › Home & field testing · 9 Jun 2025 · 0 likes Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids. Peptide-specific tests rely on protein recognition, not…
-
Subcutaneous absorption kinetics and site differences Replied, post #7 · Pharmacology › Pharmacokinetics · 7 Jun 2025 · 18 likes Hepatic metabolism: the degree to which each compound is hepatically metabolised versus renally cleared is known but varies. Severe liver disease changes clearance.
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #12 · Compounds › Secretagogues & GH axis · 4 Jun 2025 · 7 likes Picking up post #9: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #14 · Evidence › Journal club · 24 May 2025 · 28 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
Pregnancy as an absolute contraindication Replied, post #89 · Safety › Contraindications · 20 May 2025 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #79 · Data & Tools › Calculators · 20 May 2025 · 6 likes The calculators maintained on this site are open-source and verifiable. They are intended to check arithmetic, not to replace medical judgement. Using them is optional…
-
Second pass at: Designing a personal experiment that could change your mind Replied, post #26 · Research Methods › N-of-1 designs · 19 May 2025 · 5 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #11 · Practice › Reconstitution · 12 May 2025 · 20 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #25 · Outcomes › Body composition · 10 May 2025 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #32 · Clinical › Comorbidities · 3 May 2025 · 6 likes Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed resolution was more frequent on treatment. Histological resolution is a surrogate…
-
Follow-up: Documentation that appears only after payment Replied, post #35 · Sourcing › Red flags · 30 Apr 2025 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #59 · Practice › Reconstitution · 28 Apr 2025 · 30 likes I read post #57 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #41 · Compounds › Retatrutide · 23 Apr 2025 · 26 likes post #40 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
An orphaned page with no inbound links Replied, post #31 · Meta › Wiki maintenance · 21 Apr 2025 · 9 likes Review dates: each maintained page has a review date (the date by which it should be checked). If a page is past its review date, flagging it here alerts the maintainer.
-
Retatrutide dose escalation in the published trials Replied, post #144 · Compounds › Retatrutide · 17 Apr 2025 · 12 likes Picking up post #141: that is the part I would want checked first. Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #61 · Compounds › Tirzepatide · 14 Apr 2025 · 23 likes Coming back to post #59, because the follow-up matters more than the original answer. SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose…
-
A newcomer's list of things that confused me, and the fixes Replied, post #8 · Start Here › Welcome · 1 Apr 2025 · 11 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
-
Carryover and the ghost peak from last week's standard Replied, post #4 · Analytics › HPLC & UHPLC · 31 Mar 2025 · 1 like On post #2 — agreed on the reasoning, with one qualification. Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a…
-
Certificates issued by the seller versus by a laboratory Replied, post #16 · Analytics › COA interpretation · 24 Mar 2025 · 13 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Fibre intake when total intake falls, and the constipation link Replied, post #42 · Nutrition & Training › Protein & intake · 19 Mar 2025 · 0 likes post #41 answers the question as asked. The question underneath it is different. Protein supplements: whey, casein, and plant-based protein powders can help hit targets…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #36 · Compounds › Tirzepatide · 10 Mar 2025 · 0 likes Worth separating two things that post #32 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Charge states for a 4 kDa peptide, worked through Replied, post #57 · Analytics › Mass spectrometry · 9 Mar 2025 · 17 likes Coming back to post #55, because the follow-up matters more than the original answer. Sample matrix effects: if a sample is dissolved in a complex matrix, other…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #71 · Compounds › Semaglutide · 20 Feb 2025 · 0 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
-
Reading a supplementary appendix and finding the interesting part Replied, post #92 · Evidence › Trials · 13 Feb 2025 · 28 likes Coming back to post #90, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Consistent declarations and why they matter more than clever ones Replied, post #11 · Sourcing › Logistics · 9 Feb 2025 · 12 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…
-
What changed in 2026, by region Replied, post #100 · Access › International · 26 Jan 2025 · 32 likes Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago.
-
Second pass at: Historical amylin analogues and what happened to them Replied, post #18 · Compounds › Cagrilintide & amylin analogues · 21 Jan 2025 · 24 likes Worth separating two things that post #14 runs together. Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety through…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #98 · Devices › Syringes & needles · 11 Jan 2025 · 6 likes On post #94 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Escalating every six weeks instead of four: what I observed over eight months Replied, post #14 · Practice › Dosing & titration · 10 Jan 2025 · 16 likes Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
-
Isotonicity and what happens when you get it wrong Replied, post #20 · Pharmacology › Formulation chemistry · 7 Jan 2025 · 10 likes Emulsification and suspensions: some formulations are emulsions or suspensions rather than solutions. Semaglutide formulations are solutions; some other compounds are…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #7 · Analytics › Mass spectrometry · 19 Dec 2024 · 5 likes Coming back to post #5, because the follow-up matters more than the original answer. Desalting before analysis: some samples need desalting to remove salts that…
-
[2026 update] How to read a forest plot, properly, from scratch Replied, post #39 · Evidence › Trials · 16 Dec 2024 · 25 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #82 · Compounds › Tirzepatide · 11 Dec 2024 · 6 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #73 · Devices › Syringes & needles · 28 Nov 2024 · 13 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Follow-up: Recovery when intake is low: what to cut first Replied, post #34 · Nutrition & Training › Resistance training · 20 Nov 2024 · 11 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #23 · Compounds › Cagrilintide & amylin analogues · 16 Nov 2024 · 0 likes Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and had a difficult tolerability profile. A weekly formulation is a…
-
Time to steady state after a dose increase Replied, post #85 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 14 likes Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the oral dose (14 mg) is so much larger than the…
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #18 · Practice › Interactions · 19 Oct 2024 · 6 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
Criticising the method without criticising the authors Replied, post #3 · Evidence › Study critique · 31 Aug 2024 · 0 likes Coming back to the opening post, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #11 · Evidence › Journal club · 6 Aug 2024 · 26 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Circumference measurements as a poor man's composition estimate Replied, post #44 · Outcomes › Body composition · 5 Aug 2024 · 21 likes Precision versus accuracy: the precision you need depends on what question you are answering. "Am I losing fat?" requires less precision than "Is my lean mass…
-
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #34 · Safety › Contraindications · 26 Jul 2024 · 2 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
-
Pen wastage and its effect on real cost Replied, post #10 · Access › Pricing · 24 Jul 2024 · 16 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Journal club: FLOW and the renal composite, component by component Replied, post #88 · Evidence › Journal club · 17 Jul 2024 · 0 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…